Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action

To the Commissioner for Trademarks:

Application serial no. 88406770  (Stylized and/or with Design, see http://uspto.report/TM/88406770/mark.png) has been amended as follows:

ARGUMENT(S)
In response to the substantive refusal(s), please note the following:

Arguments are attached in the Evidence section.

EVIDENCE
Evidence in the nature of 1) Amendment and Response to Office Action and 2) Declaration of Andrew Thomas has been attached.
Original PDF file:
evi_15251481-20200221111912655308_._ffice_Action_Response_Product_Configuration_ELLIPTA_88406770.pdf
Converted PDF file(s) ( 1 page)
Evidence-1
Original PDF file:
evi_15251481-20200221111912655308_._88-406770_Declaration_of_Andrew_Thomas.pdf
Converted PDF file(s) ( 8 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
Evidence-7
Evidence-8

OWNER AND/OR ENTITY INFORMATION
Applicant proposes to amend the following:
Current: Glaxo Group Limited a(n) private company limited by shares (prc), legally organized under the laws of United Kingdom, having an address of
      980 Great West Road
      Brentford, Middlesex, TW89GS
      United Kingdom

Proposed: Glaxo Group Limited, private company limited by shares (prc) legally organized under the laws of United Kingdom, having an address of
      980 Great West Road
      Brentford, Middlesex, TW89GS
      United Kingdom
      Email Address: XXXX
Correspondence Information (current):
      Christopher M. Hanes
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is 82774941.
Correspondence Information (proposed):
      Christopher M. Hanes
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is 82774941.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)
Response Signature
Signature: /Christopher M. Hanes/     Date: 02/21/2020
Signatory's Name: Hanes, Christopher M.
Signatory's Position: Attorney of record, NC bar member

Signatory's Phone Number: 919-483-2723

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    Christopher M. Hanes
   GSK
   Five Moore Drive
   LBP, 5.5A
   Research Triangle Park, North Carolina 27709-3398
Mailing Address:    Christopher M. Hanes
   GSK
   Five Moore Drive
   LBP, 5.5A
   Research Triangle Park, North Carolina 27709-3398
        
Serial Number: 88406770
Internet Transmission Date: Fri Feb 21 12:19:50 ET 2020
TEAS Stamp: USPTO/ROA-XXX.XX.XX.X-202002211219507210
61-88406770-710d599dbed436b4187dcf11c9ba
2ee1418cc664538845971a0a1ec11ec11448f0-N
/A-N/A-20200221111912655308